Business Description
Eli Lilly and Co
NAICS : 325412
SIC : 2834
ISIN : US5324571083
Description
Financial Strength
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.12 | |||||
Equity-to-Asset | 0.19 | |||||
Debt-to-Equity | 2.13 | |||||
Debt-to-EBITDA | 2.57 | |||||
Interest Coverage | 22.56 | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | 9.57 | |||||
Beneish M-Score | -1.65 | |||||
WACC vs ROIC |
Growth Rank
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 12 | |||||
3-Year EBITDA Growth Rate | -1 | |||||
3-Year EPS without NRI Growth Rate | -7.3 | |||||
3-Year Book Growth Rate | 26.6 | |||||
Future 3-5Y EPS without NRI Growth Rate Estimate | 69.12 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 27.3 |
Momentum Rank
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
9-Day RSI | 0.04 | |||||
14-Day RSI | 0.82 | |||||
6-1 Month Momentum % | 19.72 | |||||
12-1 Month Momentum % | 66.67 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 1.11 | |||||
Quick Ratio | 0.87 | |||||
Cash Ratio | 0.12 | |||||
Days Inventory | 273.38 | |||||
Days Sales Outstanding | 81.94 | |||||
Days Payable | 125.76 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Dividend Yield % | 0.59 | |||||
Dividend Payout Ratio | 0.54 | |||||
3-Year Dividend Growth Rate | 15.2 | |||||
Forward Dividend Yield % | 0.61 | |||||
5-Year Yield-on-Cost % | 1.19 | |||||
3-Year Average Share Buyback Ratio | 2 | |||||
Shareholder Yield % | -0.34 |
Profitability Rank
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 80.75 | |||||
Operating Margin % | 36.28 | |||||
Net Margin % | 18.86 | |||||
FCF Margin % | -9.26 | |||||
ROE % | 61.77 | |||||
ROA % | 11.75 | |||||
ROIC % | 25.06 | |||||
3-Year ROIIC % | 15.99 | |||||
ROC (Joel Greenblatt) % | 67.68 | |||||
ROCE % | 24.2 | |||||
Years of Profitability over Past 10-Year | 9 |
GF Value Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 104.29 | |||||
Forward PE Ratio | 37.45 | |||||
PE Ratio without NRI | 93.16 | |||||
Shiller PE Ratio | 151.65 | |||||
PEG Ratio | 8.71 | |||||
PS Ratio | 19.65 | |||||
PB Ratio | 56.22 | |||||
Price-to-Tangible-Book | 654.87 | |||||
Price-to-Operating-Cash-Flow | 169.37 | |||||
EV-to-EBIT | 86.48 | |||||
EV-to-Forward-EBIT | 34.39 | |||||
EV-to-EBITDA | 74.05 | |||||
EV-to-Forward-EBITDA | 32.26 | |||||
EV-to-Revenue | 21.36 | |||||
EV-to-Forward-Revenue | 14.35 | |||||
EV-to-FCF | -229.19 | |||||
Price-to-Projected-FCF | 14.76 | |||||
Price-to-Median-PS-Value | 3.41 | |||||
Price-to-Peter-Lynch-Fair-Value | 11.96 | |||||
Price-to-Graham-Number | 52.22 | |||||
Earnings Yield (Greenblatt) % | 1.16 | |||||
FCF Yield % | -0.45 | |||||
Forward Rate of Return (Yacktman) % | 8.16 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Eli Lilly and Co Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil CHF) | 34,527.449 | ||
EPS (TTM) (CHF) | 7.175 | ||
Beta | -0.51 | ||
Volatility % | 30.19 | ||
14-Day RSI | 0.82 | ||
14-Day ATR (CHF) | 3.023027 | ||
20-Day SMA (CHF) | 773 | ||
12-1 Month Momentum % | 66.67 | ||
52-Week Range (CHF) | 510 - 850 | ||
Shares Outstanding (Mil) | 900.43 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 4 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Eli Lilly and Co Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Eli Lilly and Co Stock Events
Event | Date | Price(CHF) | ||
---|---|---|---|---|
No Event Data |
Eli Lilly and Co Frequently Asked Questions
What is Eli Lilly and Co(CHIX:LLYz)'s stock price today?
When is next earnings date of Eli Lilly and Co(CHIX:LLYz)?
Does Eli Lilly and Co(CHIX:LLYz) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |